Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a combination treatment of fimasartan and atorvastatin in essential hypertension with dyslipidemia has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Essential Hypertension

Drugs mentioned

• Fimasartan/Atorvastatin

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension, Dyslipidemia | Phase 3 | Status: COMPLETED